PCSS-MOUD Webinar: Understanding Kratom: Consumption Patterns and Treatment Strategies for Kratom Addiction

If this email does not display properly, please {View as Webpage}

Understanding Kratom: Consumption Patterns and Treatment Strategies for Kratom Addiction

Thursday | May 16, 2024 | 1:00 pm - 2:00 pm ET

Presenter: Cornel Stanciu, MD

Sponsor: American Academy of Addiction Psychiatry (AAAP)

Cost: No Fee

Target audience: Interprofessional Teams, Nurses, Pharmacists, Physician Assistants, Physicians, Psychiatrists, Psychologists, Social Workers, Students and Educators

Credit designations available: AMA PRA Category 1 Credit™, AAPA Category 1 CME, Social Work CE Credit, Pharmacy CE Credit, Interprofessional Continuing Education (IPCE) Credit

About the webinar: This webinar aims to offer a comprehensive update on kratom, a botanical increasingly prevalent among the U.S. population. There is a significant knowledge gap concerning the intersection of its purported therapeutic benefits and associated risks, including the potential for overdose and addiction. Understanding the current literature on kratom's use as a harm reduction tool by those with opioid addiction, as well as the toxicities associated with available kratom products in the United States, is crucial. Additionally, we will explore the risk of developing kratom addiction and strategies for effective management. Clinicians will gain the necessary knowledge to engage in informed discussions with kratom users and implement evidence-based treatment approaches for those who develop addiction.

Educational objectives: At the conclusion of this activity participants should be able to:

Understand kratom's literature, covering its uses, risks (overdose, addiction), and product toxicities.
Evaluate kratom's role in harm reduction, distinguishing between evidence-based practices and misconceptions
Implement evidence-based treatments for kratom addiction, facilitating informed discussions and effective interventions with patients

Continuing Education Information

In support of improving patient care, American Academy of Addiction Psychiatry is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Designation Statement

American Academy of Addiction Psychiatry designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses and Nurse Practitioners

American Academy of Addiction Psychiatry is an approved provider of nursing continuing education through AAAP’s Joint Accreditation provider #4008192. This activity is approved for up to 1 CNE credits.

PA Designation Statement

American Academy of Addiction Psychiatry has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for a maximum of 1 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Social Work Designation Statement

As a Jointly Accredited Organization, American Academy of Addiction Psychiatry (AAAP) is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. AAAP maintains responsibility for this course. Social workers completing this course receive 1 continuing education credit.

Interprofessional Continuing Education (IPCE) Designation Statement:

This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education credits for learning and change.

Pharmacy Designation Statement

This activity has been approved for 1 hours of pharmacy continuing education credit. The approval numbers issued are Universal Activity Numbers: JA4008192-0000-24-021-L01-P (pharmacy).

Other Health Professionals

Participants will receive a Certificate of Attendance stating this program is designated for AMA PRA Category 1 Credits™.

Look for more information about treating chronic pain and opioid use disorder and additional trainings at www.pcssNOW.org.

Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.